Patients, consumers and carers are involved as either representatives of European Union (EU) patients' and consumers' organisations, representatives of their own organisation or as individual experts depending on the nature of the activity.
- Representing their community
- Representing their organisation
- Patients' and Consumers' Working Party (PCWP)
- EMA consultations
- Workshops
- As individual experts
- Scientific advice / protocol assistance procedures
- Scientific advisory / ad hoc expert groups
- Scientific committee consultations
- Review of documents
Overview of patient involvement along the medicines lifecycle at EMA
Patients can get involved in every aspect of the regulatory lifecycle of a medicine from pre-submission and evaluation through to post-authorisation.
They participate in committee and expert meetings and also contribute to certain types of documents.
Lifecycle overview of involvement in meetings and outputs
Early dialogue in medicine development
Areas of involvement:
Orphan designation
COMP
Public summaries of orphan designation
Advanced therapy classification
CAT
Paediatric investigation plan
PDCO
Scientific advice
SAWP
Evaluation and authorisation
Areas of involvement:
Marketing authorisation evaluation
CHMP | CAT | PRAC
Package leaflet (new) | Medicine overview
Orphan designation maintenance
COMP
Scientific advisory / ad hoc expert groups
CHMP | PRAC
Safety monitoring of medicines
Areas of involvement:
Post marketing procedures
CHMP | CAT | PRAC
Package leaflet (renewal) | Safety communications
Scientific advisory / ad hoc expert groups
CHMP | PRAC
Public hearings
PRAC
Getting involved by representing an organisation
Any not-for-profit organisation that fulfils the following eligibility criteria is welcome to express its interest in getting involved in the work of EMA:
- legitimacy, with statutes registered in the European Union (EU);
- clear mission and objectives with an interest in medicines;
- being representative of patients or consumers throughout the EU;
- adequate structure and consultation modalities;
- transparency.
For full details, see:
Interested organisations should fill in the following application form and send it to EMA together with any supporting information. The Agency welcomes applications at any time and will send an acknowledgment of receipt after receiving the application:
EMA will inform all organisations of the outcome of the evaluation of their application. EMA publishes information on eligible organisations on Eligible patients' and consumers' organisations.
Please note that eligibility is re-assessed annually. For more information, see:
Getting involved as an individual expert
Patient experts contribute their clinical expertise directly into scientific regulatory discussions.
EMA contacts experts primarily via its network of eligible organisations.
Patient representatives interested in engaging with EMA can express their interest by registering to be included in EMA's individual stakeholder database via the link below.
The database’s main purpose is to identify patient representatives to participate in EMA activities and disseminate information relevant to individuals’ areas of interest.
Individuals invited to participate in EMA activities must register in EMA's experts database as ‘medicines experts’ before taking part, particularly in acitivities related to medicine assessment. EMA will provide instructions on how to create an account and complete the registration process.
In parallel, you can also choose to apply to EMA's open calls for remunerated external experts:
All experts involved in EMA activities must comply with the Agency’s competing interests policy.